+44 1478 350008Cell & Developmental Biology : Citations & Metrics Report
Articles published in Cell & Developmental Biology have been cited by esteemed scholars and scientists all around the world. Cell & Developmental Biology has got h-index 15, which means every article in Cell & Developmental Biology has got 15 average citations.
Following are the list of articles that have cited the articles published in Cell & Developmental Biology.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
30 | 30 | 26 | 5 | 8 |
Year wise citations received |
123 | 142 | 124 | 118 | 105 |
| Journal total citations count | 951 |
| Journal impact factor | 5.1 |
| Journal 5 years impact factor | 6.8 |
| Journal cite score | 7.0 |
| Journal h-index | 15 |
| Journal h-index since 2018 | 12 |
Important citations (614)
Lu dy, lu tr, chen eh, xu b, yarla ns, zhu h, ding j. anticancer drug development, system updating and global participations. current drug therapy. 2017 jan 1;12(1):37-45. |
|
Lu dy, lu tr, ding j, xu b, che jy, wu hy. anticancer drug sensitivity testing, a historical review and future perspectives. current drug therapy. 2015 apr 1;10(1):44-55. |
|
Lu dy, lu tr, cao s. individualized cancer chemotherapy by detecting cancer biomarkers. metabolomics. 2012;2(5):e121. |
|
Lu dy, lu tr, wu hy. cost-effectiveness considerations of individualized cancer chemotherapy. advances in pharmacoepidemiology & drug safety. 2013;2(5):e121. |
|
Lu d, lu t, zhu h, ding j, xu b, wu hy, wu sy, yarla ns. anticancer drug development, getting out from bottleneck. med chem (los angeles). 2017;7:739-44. |
|
Lu dy, lu tr, yarla ns, wu hy, xu b, ding j, zhu h. drug combination in clinical cancer treatments. reviews on recent clinical trials. 2017 sep 1;12(3):202-11. |
|
Lu dy, lu tr, wu hy. combination chemical agents with biological means in cancer therapy. research and reviews in bioscience. 2013;7(4):153-5. |
|
Lu dy, chen eh, ding j, xu b, lu tr. anticancer drug combinations, a big momentum is needed. metabolomics. 2015;5(3):e139. |
|
Lu dy, lu tr, wu hy. new insights into individualized antimetastatic therapy. advanced techniques in biology & medicine. 2013 apr 26;1(1):106. |
|
Lu dy, chen eh, lu tr. anticancer drug development, a matter of money or a matter of idea. metabolomics. 2015;5(2):e134. |
|
Lu dy, lu tr, cao s. drug combinations in cancer treatment. clin exp pharmacol. 2013;3(4):134. |
|
Lu dy, lu tr, wu hy. personalized cancer therapy, a perspective. clin exp pharmacol. 2014;4(2):153. |
|
Lu dy, lu tr, xu b, ding j. pharmacogenetics of cancer therapy: breakthroughs from beyond?. future science oa. 2015 nov;1(4). |
|
Lu dy, lu tr, wu hy, cao s. cancer metastasis treatments. current drug therapy. 2013 mar 1;8(1):24-9. |
|
Lu dy, chen eh, wu hy, lu tr, xu b, ding j. anticancer drug combinations, how far we can go through?. anti-cancer agents in medicinal chemistry (formerly current medicinal chemistry-anti-cancer agents). 2017 jan 1;17(1):21-8. |
|
Lu dy, zhu pp, lu tr, che jy. the suicidal risks and treatments, seek medications from multi-disciplinary. central nervous system agents in medicinal chemistry (formerly current medicinal chemistry-central nervous system agents). 2016 dec 1;16(3):231-9. |
|
Lu dy, lu tr, zhu pp, che jy. the efficacies and toxicities of antidepressant drugs in clinics, building the relationship between chemo-genetics and socio-environments. central nervous system agents in medicinal chemistry (formerly current medicinal chemistry-central nervous system agents). 2016 apr 1;16(1):12-8. |
|
Lu dy, lu tr, che jy, zhu pp. genetic and bioinformatic studies of antidepressant drug therapeutic efficacy and toxicity: a current overview. recent patents on cns drug discovery. 2014 dec 1;9(3):193-9. |
|
Chanu si, varsha ss. modeling human neurodegenerative tauopathies in animal models: focus on drosophila melanogaster. adv tech biol med. 2014;2:e104. |
|
Dhama n, babu a, sharma n. research & reviews: journal of medical and health sciences. |
|